Studies showed that high expression of Id1 is associated with poor prognosis in patients with AML, independently predicting shorter disease-free survival and overall survival 39, 40, especially for those with higher risk karyotype classification in young non-M3 patients 41. This evidence concerns the gene ID1 and acute myeloid leukemia.